Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.25.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.25.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.16.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.57.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.57.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.44.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.44.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDP.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.5NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KR.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KZ.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KZ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KS.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.19NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.47NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.23NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.2.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.4.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LK.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDSNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LY.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
LY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDD.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KR.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
MD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.64.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.64.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HN.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
DV.7.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.20.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used